Eli Lilly Raises Guidance After Strong Weight-Loss Drug Sales Drive Record Earnings
Oct 30, 2025
Eli Lilly reported third-quarter financial results that were much better than expected. The company saw a large increase in revenue, rising 54% to $17.60 billion, and posted earnings per share of $7.02 on an adjusted basis. These results exceeded analyst estimates.
The main reason for the strong performance was soaring demand for Eli Lilly’s weight-loss drug Zepbound and diabetes treatment Mounjaro, which belong to a class of medicines known as GLP-1s. Sales of Zepbound nearly tripled during the quarter, contributing significantly to the company’s record results.
Based on these results, Eli Lilly raised its full-year forecast for both profit and revenue, indicating that it expects the strong demand for its weight-loss drugs to continue. The company's stock rose as much as 4% following the release of the earnings report.
Eli Lilly is working to maintain its position as a leader in the growing market for obesity and diabetes treatments, facing competition from other major drugmakers.
Why did Eli Lilly's revenue and profit increase so much?
Eli Lilly's revenue and profit rose mainly because of strong sales of its weight-loss and diabetes drugs, especially Zepbound and Mounjaro.
What are GLP-1 drugs?
GLP-1 drugs are medicines used to help people lose weight or manage diabetes. They work by influencing how the body regulates blood sugar and appetite.
How did the market react to Eli Lilly's earnings report?
Eli Lilly's shares increased by nearly 4% after the company reported earnings that were much better than expected and raised its profit forecast.
Is Eli Lilly facing competition with these drugs?
Yes, Eli Lilly is competing with other companies in the fast-growing market for obesity and diabetes treatments.
Sources
Eli Lilly Reports Earnings Thursday as Investors Await Trump Drug Pricing Deal
Barrons
Barrons
The drugmaker Eli Lilly reports its third-quarter results early Thursday, as questions loom about what kind of deal it will reach with the Trump administration over the price of its weight-loss drug.
Eli Lilly Raises Outlook on Soaring GLP-1 Demand
WSJ
WSJ
Eli Lilly reported higher third-quarter profit and raised its full-year outlook on the back of surging demand for its GLP-1 weight-loss drugs.
Eli Lilly raises full-year forecast, sees sustained demand for weight-loss drugs
Reuters
Reuters
Eli Lilly raised its full-year profit and revenue forecast on Thursday, betting on surging demand for its blockbuster GLP-1 drugs.
Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales so...
CNBC
CNBC
Eli Lilly reported third-quarter earnings and revenue that topped estimates and hiked its full-year outlook, as the company continued to see strong demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro. The results come as Eli Lilly works to maintain its edge over chie...
Lilly reports third-quarter 2025 financial results, highlights R&D pipeline mome...
Revenue in Q3 2025 increased 54% to $17.60 billion driven by volume growth from Mounjaro and Zepbound. Q3 2025 EPS increased by $5.14 to $6.21 on a reported basis and increased by $5.84 to $7.02 on a non-GAAP basis.
Eli Lilly's stock jumps as Zepbound sales nearly triple at lower prices
Market Watch
Market Watch
Eli Lilly's stock rallies, as Zepbound sales nearly tripled, leading to record revenue and a raised full-year outlook.
Eli Lilly Blows Away Q3 Earnings Expectations
24/7 Wall Street
24/7 Wall Street
Eli Lilly (NYSE: LLY) delivered a commanding third quarter, posting earnings and revenue that significantly exceeded expectations while raising full-year guidance.
Eli Lilly shares jump as blowout earnings, obesity drug demand fuel profit upgra...
Invezz
Invezz
Shares of Eli Lilly rose nearly 4% in premarket trading on Thursday after the pharmaceutical company reported third-quarter earnings that exceeded expectations and lifted its annual profit forecast. The company posted adjusted earnings of $7.02 per share for the quarter, well ahead of analysts' cons...
Eli Lilly Q3 earnings and revenue top estimates, boosted by weight loss drug dem...
Proactive Investors
Proactive Investors
Eli Lilly and Co (NYSE:LLY) on Thursday reported third quarter 2025 financial results that handily beat Wall Street forecasts, as the company continued to see strong demand for its weight loss drug Zepbound and diabetes treatment Mounjaro. The pharmaceutical giant's revenue for the quarter rose 54%...
Eli Lilly Blows Past Expectations On The Back Of Mounjaro, Zepbound
Investors Business Daily
Investors Business Daily
Eli Lilly stock jumped early Thursday after the drugmaker easily topped third-quarter forecasts on the back of its two biggest drugs.
Eli Lilly CEO: Seeing global demand for weight loss drug Mounjaro
CNBC Television
CNBC Television
Eli Lilly chairman and CEO David Ricks joins CNBC's “Squawk on the Street” team to discuss its quarterly earnings report that beat estimates, weight loss drug demand, its drug pipeline and more.
Mounjaro And Zepbound Power Eli Lilly's 54% Revenue Jump In Q3, Hikes 2025 Forec...
Benzinga
Benzinga
Eli Lilly and Co. (NYSE:LLY) on Thursday reported better-than-expected third-quarter earnings and boosted its annual forecast, sending the stock higher.
Compared to Estimates, Lilly (LLY) Q3 Earnings: A Look at Key Metrics
Zacks Investment Research
Zacks Investment Research
The headline numbers for Lilly (LLY) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Eli Lilly Boosts Its Outlook on High Demand for Popular Weight-Loss Drugs
Investopedia
Investopedia
Strong sales of Eli Lilly's weight-loss treatments Mounjaro and Zepbound helped power strong quarterly earnings, and the drugmaker boosted its outlook.
BMY Beats on Q3 Earnings and Sales, Raises 2025 Sales View
Zacks Investment Research
Zacks Investment Research
Bristol-Myers' strong Q3 results, powered by Opdivo, Reblozyl and Breyanzi, led to a revenue guidance boost despite legacy drug declines.
Lilly Beats on Q3 Earnings, Ups View, Mounjaro, Zepbound Drive Sales
Zacks Investment Research
Zacks Investment Research
Lilly tops Q3 estimates as Mounjaro and Zepbound fuel a 54% revenue surge, prompting the drugmaker to raise its full-year sales and earnings outlook.
Estee Lauder Q1 Earnings Beat Estimates, Sales Up 4% Y/Y
Zacks Investment Research
Zacks Investment Research
EL posts Q1 earnings and sales beats, fueled by fragrance demand, PRGP savings and Asia-Pacific growth momentum.
Eli Lilly and Company (LLY) Q3 2025 Earnings Call Transcript
Seeking Alpha
Seeking Alpha
Eli Lilly and Company ( LLY ) Q3 2025 Earnings Call October 30, 2025 10:00 AM EDT Company Participants Mike Czapar - Director of Investor Relations David Ricks - Chairman, CEO & President Lucas Montarce - Executive VP & CFO Daniel Skovronsky - EVP, Chief Scientific Officer and President of Lilly Res...
Gilead Sciences Announces Third Quarter 2025 Financial Results
Business Wire
Business Wire
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #Earnings--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its third quarter 2025 results of operations. “We continue to deliver on Gilead's robust portfolio with a strong start for Yeztugo, rapidly growing uptake of Biktarvy, Descovy and Livdelzi, and pos...
Eli Lilly: The Price Upside Just Increased
Seeking Alpha
Seeking Alpha
Eli Lilly delivered robust Q3 2025 results and guidance for non-GAAP EPS for the second consecutive quarter. When I last checked on the stock, there was still 20% upside to LLY for the remainder of 2025. With higher guidance, this upside has risen too. Risks persist for the stock in terms of the pol...
Related Posts
Other News
Corporate Moves
View All
SentinelOne Shares Fall After CFO Departure and Weak Revenue Outlook
Dec 5, 2025
S
-14.44%
SentinelOne, a cybersecurity company, reported its third-quarter financial results, showing strong growth and improved margins. Despite this performance, the company gave a revenue forecast for the ne...
Amazon May End US Postal Service Partnership to Expand Own Delivery Network
Dec 4, 2025
AMZN
+0.18%
Amazon is reportedly considering ending its long-running contract with the United States Postal Service (USPS). This change would allow Amazon to rely more on its own growing nationwide delivery netwo...
Meta to Make Deep Cuts to Metaverse Budget as AI Becomes Priority
Dec 4, 2025
META
+1.8%
Meta Platforms CEO Mark Zuckerberg plans to significantly cut spending on the company's metaverse efforts, according to reports from Bloomberg News. The expected budget cuts could be as much as 30% fo...
Product Launches
View All
Amazon Unveils New AI Chips and Tools to Boost Cloud Capabilities
Dec 2, 2025
AMZN
+0.18%
Amazon Web Services (AWS) has introduced new artificial intelligence (AI) chips and software tools aimed at improving the performance and reliability of its cloud computing services.
A key highlight...
Samsung Launches World’s First Triple-Folding Smartphone, the Galaxy Z TriFold
Dec 2, 2025
005930
+1.34%
Samsung Electronics has unveiled its first multi-folding smartphone, the Galaxy Z TriFold. This new device folds inward twice, creating a three-panel design with a large 10-inch inner display.
The la...
Amazon and Google Launch Joint Multicloud Networking Service
Dec 1, 2025
GOOGL
+1.15%
AMZN
+0.18%
Amazon and Google have announced a new multicloud networking service to improve connectivity between their cloud platforms. This jointly developed solution is designed to provide businesses with a fas...
Regulatory Actions
View All
The New York Times Sues Perplexity AI Over Copyright Infringement
Dec 5, 2025
NYT
+1.11%
The New York Times has filed a lawsuit against Perplexity AI, accusing the artificial intelligence startup of copyright infringement. The newspaper says Perplexity copied, distributed, and displayed m...
New York Times Sues Pentagon Over Restrictive Press Rules
Dec 4, 2025
NYT
+1.11%
The New York Times has filed a lawsuit against the U.S. Department of Defense and Defense Secretary Pete Hegseth over new press rules at the Pentagon. The newspaper claims that the new policy restrict...
EU Launches Antitrust Investigation into Meta’s Use of AI in WhatsApp
Dec 4, 2025
META
+1.8%
The European Union has started an antitrust investigation into Meta Platforms, the company that owns WhatsApp, over its use of artificial intelligence (AI) features within the messaging app.
EU regul...
Earnings
View All
Broadcom Shares Rise Ahead of Key Earnings Report as Analysts Boost Targets
Dec 5, 2025
AVGO
+2.42%
Broadcom, a major semiconductor company, is drawing attention as it prepares to release its quarterly earnings next week. Both analysts and investors are optimistic, with the stock rising nearly 3% an...
Victoria's Secret Shares Jump After Strong Q3 Earnings and Higher Sales Outlook
Dec 5, 2025
VSCO
+17.99%
Victoria's Secret & Co. reported its third quarter 2025 earnings, showing stronger results than Wall Street had expected. Net sales for the quarter reached $1.472 billion, which is a 9% increase from...
DocuSign Shares Fall Despite Strong Q3 Fiscal 2026 Earnings Beat
Dec 5, 2025
DOCU
-7.64%
DocuSign announced its third quarter fiscal 2026 financial results, reporting revenue of $818.4 million for the period ending October 31, 2025. This result exceeded Wall Street's estimate of about $80...
Stock Movements
View All
Cloudflare Outage Causes Widespread Website Disruptions, Services Restored
Dec 5, 2025
NET
-1.57%
Cloudflare, an internet infrastructure company, experienced a service outage on Friday that caused several major websites to go down. Affected sites included LinkedIn, Zoom, Canva, Shopify, crypto tra...
D-Wave Quantum Stock Experiences Volatility Amid Valuation Concerns and Industry Advances
Dec 5, 2025
QBTS
-6.02%
D-Wave Quantum (QBTS) stock has recently faced significant fluctuations. Over the past 21 trading days, the stock declined by about 24.2%, drawing attention to concerns over the company's high valuati...
SoFi Announces $1.5 Billion Public Offering, Stock Falls Over 6%
Dec 5, 2025
SOFI
-6.15%
SoFi Technologies, a financial technology company, has launched a public offering to sell $1.5 billion worth of its common stock. The company priced 54,545,454 shares at $27.50 each. All of the shares...
Economy
View All
US Stock Market Holds Steady as Investors Await Key Inflation Data
Dec 5, 2025
The S&P 500 inched up by 0.15% as US stock market indexes remained close to their record highs. This comes as investors await a key inflation report, the Personal Consumption Expenditures (PCE) index....
ADP Report: Private Sector Lost 32,000 Jobs in November, Wages Up 4.4% Over Year
Dec 3, 2025
According to the November ADP National Employment Report, private sector employment in the United States decreased by 32,000 jobs. This data was compiled by ADP Research in collaboration with the Stan...
Nvidia's AI Chip Leadership Spurs Industry Growth and Component Shortages
Dec 2, 2025
NVDA
-0.53%
Nvidia, a leader in artificial intelligence (AI) chips, continues to drive strong growth in the technology sector. The company has seen high demand for its graphics processing units (GPUs), particular...
Analyst Ratings
View All
‘Big Short’ Investor Michael Burry Calls Tesla ‘Ridiculously Overvalued’
Dec 1, 2025
TSLA
+0.1%
Michael Burry, the investor known for predicting the 2008 financial crisis, has criticized Tesla's stock valuation. In a recent blog post, Burry described Elon Musk's electric car company as 'ridiculo...
Carvana Stock Upgraded by Wedbush, Price Target Raised to $400
Nov 24, 2025
CVNA
+0.23%
Carvana, an online used car retailer, saw its stock rise over 7% on Monday after analysts at Wedbush Securities upgraded the stock from 'Neutral' to 'Outperform.'
Wedbush analysts raised their 12-mon...
Dell Stock Falls After Morgan Stanley Downgrade Over Memory Chip Costs
Nov 17, 2025
DELL
-0.06%
Dell Technologies shares dropped by about 7% to $124.44 after Morgan Stanley downgraded the stock from 'overweight' to 'underweight' and lowered its price target to $110. The downgrade reflects concer...
Mergers & Acquisitions
View All
Meta Acquires AI Wearables Startup Limitless
Dec 5, 2025
META
+1.8%
Meta has announced the acquisition of Limitless, a startup that specializes in artificial intelligence-powered wearables. Limitless is known for its pendant-style device that can record and transcribe...
Netflix To Acquire Warner Bros. Discovery’s Film and Streaming Businesses in Massive Deal
Dec 5, 2025
NFLX
-2.89%
WBD
+6.28%
Netflix has agreed to acquire Warner Bros. Discovery’s film studios and streaming division, including HBO Max, in a deal valued at up to $83 billion. The agreement will make Netflix one of the largest...
Hims & Hers Expands Into Canada After Acquiring Digital Health Platform Livewell
Dec 4, 2025
HIMS
-2.05%
Hims & Hers Health, a leading US digital health company, has officially expanded its services into Canada. This move follows its recent acquisition of Livewell, a Canadian digital health platform know...
IPO
View All
Navan Raises $923 Million in IPO Amid US Government Shutdown
Oct 30, 2025
NAVN
-4.57%
Navan, a business travel and expense management company, has completed its initial public offering (IPO) by selling 36,924,406 shares of its Class A common stock at $25 per share. The IPO raised appro...
Beta Technologies Launches IPO, Aiming to Raise Up to $825 Million
Oct 16, 2025
BETA
-4.86%
Beta Technologies, a company that makes electric aircraft, has set the terms for its initial public offering (IPO) in the United States.
The company plans to offer 25 million shares of its Class A co...
Fermi Shares Surge After High-Profile IPO Despite Lack of Revenue
Oct 2, 2025
FRMI
-4.71%
Fermi Inc., a start-up focused on building large data centers for artificial intelligence, saw its stock price soar following its initial public offerings on both the Nasdaq in New York and the London...
